TP53 and diabetes mellitus: On the contrary, we observed a significant enrichment of cell cycle regulation, the p53 signaling pathway, and the MAPK signaling pathway derived from diabetes donors due to the IronQ treatment in PBMCs (Fig. 5e,f).